학술논문

Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
Document Type
Article
Source
In: The Lancet Oncology. (The Lancet Oncology, September 2022, 23(9):1156-1166)
Subject
Language
English
ISSN
14745488
14702045